Ohki Health Care Holdings, Inc. (3417) AI Stock Analysis

• Market Cap: ¥15.13B
• Dividend Yield: 2.37%
• Average Volume (3M): 20.24K
• Price to Earnings (P/E): 5.6
• Beta (1Y): 0.56
• Revenue Growth: 4.42%
• EPS Growth: 20.59%
• Country: JP
• Employees: 632
• Sector: Healthcare
• Sector Strength: 39
• Industry: Medical - Pharmaceuticals
• EPS (TTM): 67.41
• Shares Outstanding: 14,072,100
• 10 Day Avg. Volume: 13,250
• 30 Day Avg. Volume: 20,243
• PEG Ratio: 0.42
• Price to Book (P/B): 0.47
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,208.00
• Price Target Upside: 11.03% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 80 Outperform
• Price Target: ¥1,208.00 ▲(11.03%Upside)

The stock's strong technical analysis and attractive valuation are the primary drivers of its high score. However, financial performance concerns, particularly related to cash flow challenges and leverage, slightly temper the overall outlook.

Ohki Health Care Holdings, Inc. Business Overview & Revenue Model

Company Description

Ohki Health Care Holdings, Inc. (3417) is a prominent player in the health care sector, focusing on the production and distribution of pharmaceuticals, medical supplies, and related healthcare products. The company operates across various segments, including prescription and over-the-counter drugs, medical devices, and health supplements. With a commitment to improving health outcomes, Ohki Health Care Holdings leverages advanced research and development capabilities to deliver innovative healthcare solutions.

How the Company Makes Money

Ohki Health Care Holdings, Inc. generates revenue primarily through the sale of its diverse range of healthcare products, including pharmaceuticals and medical devices. The company serves both domestic and international markets, catering to hospitals, clinics, pharmacies, and other healthcare providers. Key revenue streams include sales of prescription medications, over-the-counter drugs, and health supplements. Additionally, strategic partnerships with healthcare institutions and research organizations contribute to its earnings by facilitating product development and expanding market reach. The company's focus on innovation and quality ensures a competitive edge, supporting sustained revenue growth.

Ohki Health Care Holdings, Inc. Financial Statement Overview

Summary

Ohki Health Care Holdings shows strong revenue growth and improving profit margins. However, increasing leverage and recent cash flow challenges present risks. The company's ability to enhance operational efficiency and manage debt is crucial.

Income Statement

Ohki Health Care Holdings has demonstrated a strong revenue growth trajectory with consistent increases in total revenue over the past five years. The gross profit margin showed an improvement from 4.9% in 2020 to 5.2% in 2025, indicating better cost management. The net profit margin also improved from 0.85% to 0.75%. However, there has been some volatility in EBIT margins, suggesting potential challenges in managing operating expenses efficiently.

Balance Sheet

The company's balance sheet reflects a stable equity position with stockholders' equity rising from 19.2% of total assets in 2020 to 22.2% in 2025. The debt-to-equity ratio has increased, indicating higher leverage, which could pose risks if not managed properly. Return on equity remained healthy, showing the company's ability to generate returns on shareholders' investments.

Cash Flow

Cash flow analysis reveals a concerning trend in operating cash flows, which turned significantly negative in the latest fiscal year. Free cash flow also deteriorated, suggesting challenges in maintaining liquidity. However, previous years displayed positive cash flow, indicating potential for recovery if operational efficiencies are improved.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	345.65B	349.45B	334.66B	304.44B	278.16B	270.93B
Gross Profit	17.77B	18.19B	17.20B	15.88B	13.72B	15.51B
EBITDA	3.30B	4.29B	2.42B	3.59B	1.95B	4.50B
Net Income	2.34B	2.64B	2.21B	2.18B	972.00M	2.75B
Balance Sheet
Total Assets	154.62B	139.34B	138.58B	122.54B	113.95B	110.96B
Cash, Cash Equivalents and Short-Term Investments	4.36B	2.88B	8.31B	3.24B	2.77B	2.80B
Total Debt	8.76B	14.17B	6.95B	8.46B	7.48B	8.59B
Total Liabilities	123.84B	108.28B	110.68B	98.27B	91.86B	88.82B
Stockholders Equity	30.74B	30.99B	27.84B	24.13B	21.95B	21.93B
Cash Flow
Free Cash Flow	0.00	-12.03B	7.23B	-223.00M	1.17B	-4.43B
Operating Cash Flow	0.00	-9.18B	7.55B	96.00M	1.31B	-4.27B
Investing Cash Flow	0.00	-3.13B	-496.00M	-291.00M	68.00M	710.00M
Financing Cash Flow	0.00	6.89B	-2.00B	681.00M	-1.40B	2.36B

Ohki Health Care Holdings, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1088.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3417, the sentiment is Positive. The current price of 1088 is above the 20-day moving average (MA) of 1061.55, above the 50-day MA of 1010.76, and above the 200-day MA of 862.70, indicating a bullish trend. The MACD of 14.84 indicates Positive momentum. The RSI at 56.61 is Neutral, neither overbought nor oversold. The STOCH value of 64.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3417.

Ohki Health Care Holdings, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7679	80 Outperform	¥43.80B	9.67		1.26%	6.65%	12.77%
3417	80 Outperform	¥15.13B	5.62		2.37%	4.42%	20.59%
4350	73 Outperform	¥15.18B	11.53		2.38%	6.09%	-30.07%
3544	65 Neutral	¥11.55B	14.96		1.19%	4.87%	63.01%
2796	62 Neutral	¥5.82B	―		2.82%	16.60%	-19.16%
8095	60 Neutral	¥19.20B	8.67		3.80%	11.92%	-237.35%
Sector *	59 Neutral	HK$15.54B	5.61	-7.44%	4.07%	11.55%	-28.15%